Balancing Drug Efficacy and Patient Benefit

This chapter delves into the challenges of prescribing expensive medications like GLP-1s and SGLT2 inhibitors for diabetes and chronic kidney disease patients. It highlights the need to balance clinical benefits with affordability, while drawing parallels to historical practices in cardiology.